Back
CureVac NV 10K Form
Sell
24
CVAC
CureVac NV
Last Price:
$5.12
Seasonality Move:
-21.5%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CVAC News And Ratings
See the #1 stock for the next 7 days that we like better than CVAC
CVAC Financial Statistics
Sales & Book Value
| Annual Sales: | $578.9M |
|---|---|
| Cash Flow: | $31.6M |
| Price / Cash Flow: | 6 |
| Annual Sales: | $4.55 |
| Price / Book: | 1.14 |
Profitability
| EPS (TTM): | 0.71460 |
|---|---|
| Net Income (TTM): | $162M |
| Gross Margin: | $443.4M |
| Return on Equity: | 20.55% |
| Return on Assets: | 17.11% |
CureVac NV Earnings Forecast
Key CureVac NV Financial Ratios
-
The Gross Profit Margin over the past 7 years for CVAC is 76.60%.
-
The Selling, General & Administrative Expenses for CVAC have been equal to 13.85% of Gross Profit Margin.
-
The Research & Development expenses have been 26.43% of Revenue.
-
The Interest Expense is 0.51% of Operating Income.
-
The Net Earning history of CVAC is 30.30% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 3 years.
CureVac NV Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CVAC |
| Website: | curevac.com |
Debt
| Debt-to-Equity Ratio: | 0.04 |
|---|---|
| Current Ratio: | 3.7 |
| Quick Ratio: | 1.84 |
Price-to-Earnings
| Trailing P/E Ratio: | 6.6 |
|---|---|
| Forward P/E Ratio: | 0 |
CVAC Technical Analysis vs Fundamental Analysis
Sell
24
CureVac NV (CVAC)
is a Sell
Is CureVac NV a Buy or a Sell?
-
CureVac NV stock is rated a SellThe current CureVac NV [CVAC] share price is $5.12. The Score for CVAC is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.